Activated Protein C Resistance (Factor V Leiden G1691A mutation), by PCR
3Day(s)This test is useful in the differential diagnosis of hereditary thrombophilia. Around 20% of heterozygotes and 40% of homozygotes develop thrombosis at an average age of 36 and 25 respectively. The relative risk of venous thrombosis for carriers of this mutation is estimated to be 5-10-fold increase for heterozygote and 50-100-fold increase for homozygote individuals. See Activated Protein C Resistnace (Factor V Leiden), Functional; Protein C Antigen Assay; and Protein S Total and Free.
متطلبات خاصة
Results released on Mon. & Thu. Collect in EDTA vacutainer tube. Avoid contamination with DNA of phlebotomist. Avoid haemolysed samples. Send tube unopened.
Copyright © biolab 2018, Developed by Tech Factory